Virtus KAR Health Sciences Fund Inst (HLHIX)
35.59
-0.18
(-0.50%)
USD |
Nov 16 2026
Key Stats
| Net Expense Ratio | Total Assets Under Management | Weighted Average Dividend Yield | Turnover Ratio (Generic) |
|---|---|---|---|
| 1.05% | 105.25M | 0.73% | 13.00% |
| 1 Year Fund Level Flows | 1 Year Total Returns (Daily) | Annualized Total Returns Since Inception (Daily) | Max Drawdown (Since Inception) |
| -15.76M | 17.77% |
Basic Info
| Investment Strategy | |
| The Fund seeks long-term capital appreciation by investing at least 65% of its assets in healthcare sector equity securities. Under normal market conditions, the fund will invest at least 65% of its assets will be invested in companies located in at least three different countries, including possibly the United States. |
| General | |
| Security Type | Mutual Fund |
| Equity Style | Multi Cap Core |
| Broad Asset Class | Sector Equity |
| Broad Category | Equity |
| Global Peer Group | Equity Sector Healthcare |
| Peer Group | Health/Biotechnology Funds |
| Global Macro | Equity Industry Sector |
| US Macro | Sector Equity Funds |
| YCharts Categorization | -- |
| YCharts Benchmark | -- |
| Prospectus Objective | Health/Biotechnology Funds |
| Fund Owner Firm Name | Virtus |
| Broad Asset Class Benchmark Index | |
| ^MSWNTR | 100.0% |
Net Fund Flows Versus Peer Group
1 Month
% Rank:
52
-113.65M
Peer Group Low
1.378B
Peer Group High
1 Year
% Rank:
55
-15.76M
-1.720B
Peer Group Low
2.216B
Peer Group High
3 Months
% Rank:
56
-294.00M
Peer Group Low
1.507B
Peer Group High
3 Years
% Rank:
39
-6.761B
Peer Group Low
1.019B
Peer Group High
6 Months
% Rank:
59
-717.06M
Peer Group Low
1.172B
Peer Group High
5 Years
% Rank:
39
-9.137B
Peer Group Low
4.443B
Peer Group High
YTD
% Rank:
59
-1.316B
Peer Group Low
1.675B
Peer Group High
10 Years
% Rank:
36
-12.43B
Peer Group Low
11.17B
Peer Group High
Date Unavailable
Risk
Performance Versus Peer Group
Annual Total Returns Versus Peers
As of November 17, 2026.
Asset Allocation
As of June 30, 2026.
| Type | % Net |
|---|---|
| Cash | 0.00% |
| Stock | 98.48% |
| Bond | 0.00% |
| Convertible | 0.00% |
| Preferred | 0.00% |
| Other | 1.52% |
Top 10 Holdings
| Name | % Weight | Price | % Change |
|---|---|---|---|
| Eli Lilly & Co. | 14.84% | 1415.80 | -1.11% |
| West Pharmaceutical Services, Inc. | 5.92% | 416.56 | -0.30% |
| AbbVie, Inc. | 5.52% | 293.19 | -0.46% |
| Vertex Pharmaceuticals, Inc. | 5.32% | 534.88 | -0.54% |
| Merck & Co., Inc. | 5.06% | 143.87 | -0.41% |
| UnitedHealth Group, Inc. | 4.65% | 396.99 | -3.65% |
| McKesson Corp. | 4.57% | 1095.34 | -0.88% |
| Mettler-Toledo International, Inc. | 3.99% | 1721.34 | -0.34% |
| Intuitive Surgical, Inc. | 3.89% | 432.54 | -1.19% |
| Amgen, Inc. | 3.85% | 458.94 | -0.73% |
Fees & Availability
| Fees | |
| Actual 12B-1 Fee | -- |
| Actual Management Fee | 0.72% |
| Administration Fee | 6159.00 None |
| Maximum Front Load | -- |
| Maximum Deferred Load | -- |
| Maximum Redemption Fee | -- |
| General Availability | |
| Available for Insurance Product | No |
| Available for RRSP | No |
| Purchase Details | |
| Open to New Investors |
|
| Minimum Initial Investment | 1.00M None |
| Minimum Subsequent Investment | 0.00 None |
TTM Distributions
| Type | Nov | Dec | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Qualified Income
|
-- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
|
Normal
|
-- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
|
Qualified
|
-- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
|
LT Cap Gains
|
-- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
|
Ordinary Income
|
-- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
|
Non-Qual
|
-- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
|
ST Cap Gains
|
-- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
|
Interest
|
-- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
|
Tax-Exempt
|
-- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
|
ROC
|
-- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
|
Other
|
-- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
|
Total
|
-- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
As of October 31, 2026.
Basic Info
| Investment Strategy | |
| The Fund seeks long-term capital appreciation by investing at least 65% of its assets in healthcare sector equity securities. Under normal market conditions, the fund will invest at least 65% of its assets will be invested in companies located in at least three different countries, including possibly the United States. |
| General | |
| Security Type | Mutual Fund |
| Equity Style | Multi Cap Core |
| Broad Asset Class | Sector Equity |
| Broad Category | Equity |
| Global Peer Group | Equity Sector Healthcare |
| Peer Group | Health/Biotechnology Funds |
| Global Macro | Equity Industry Sector |
| US Macro | Sector Equity Funds |
| YCharts Categorization | -- |
| YCharts Benchmark | -- |
| Prospectus Objective | Health/Biotechnology Funds |
| Fund Owner Firm Name | Virtus |
| Broad Asset Class Benchmark Index | |
| ^MSWNTR | 100.0% |
Fundamentals
| General | |
| Distribution Yield | -- |
| Dividend Yield TTM (11-16-26) | 0.00% |
| 30-Day SEC Yield | -- |
| 7-Day SEC Yield | -- |
| Number of Holdings | 25 |
| Stock | |
| Weighted Average PE Ratio | 37.21 |
| Weighted Average Price to Sales Ratio | 7.230 |
| Weighted Average Price to Book Ratio | 9.831 |
| Weighted Median ROE | 444.2% |
| Weighted Median ROA | 12.77% |
| Return on Investment (TTM) | 19.16% |
| Earning Yield | 0.0309 |
| LT Debt / Shareholders Equity | 0.9105 |
| Number of Equity Holdings | 24 |
As of June 30, 2026
Growth Metrics
| EPS Growth (1Y) | 36.50% |
| EPS Growth (3Y) | 13.16% |
| EPS Growth (5Y) | 15.03% |
| Sales Growth (1Y) | 13.75% |
| Sales Growth (3Y) | 11.93% |
| Sales Growth (5Y) | 12.40% |
| Sales per Share Growth (1Y) | 15.04% |
| Sales per Share Growth (3Y) | 12.42% |
| Operating Cash Flow - Growth Rate (3Y) | 10.87% |
As of June 30, 2026
Fund Details
| Key Dates | |
| Inception Date | 12/22/2014 |
| Last Annual Report Date | 6/30/2026 |
| Last Prospectus Date | 10/28/2026 |
| Share Classes | |
| RAGHX | A |
| Attributes | |
| Index Fund | -- |
| Inverse Fund | No |
| Leveraged Fund | -- |
| Fund of Funds | No |
| Currency Hedged Fund | -- |
| Socially Responsible Fund | No |
Top Portfolio Holders
| Name | % Weight |
|---|---|
| Portfolio A | 5.00% |
| Portfolio B | 3.50% |
| Portfolio C | 2.25% |
Excel Add-In Codes
| Name: =YCI("M:HLHIX", "name") |
| Broad Asset Class: =YCI("M:HLHIX", "broad_asset_class") |
| Broad Category: =YCI("M:HLHIX", "broad_category_group") |
| Prospectus Objective: =YCI("M:HLHIX", "prospectus_objective") |
| To find the codes for any of our securities and financial metrics, see our Complete Excel Reference. |